28 December 2021| 4:00 PM

Vaccination figures: 20-26 December 2021

By Sunday 26 December, it is estimated that more than 24.6 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.3 million were second vaccinations.  

Vaccination coverage for the basic series

It is estimated that 89.1% of all people over 18 have received at least one vaccination in the basic series, and 85.9% have completed the basic series. It is estimated that 87.3% of all people over 12 have received at least one vaccination in the basic series, and 84.3% have completed the basic series. 

Read more about COVID-19 vaccination figures. 

28 December 2021 | 3:20 PM

Weekly update on the coronavirus SARS-CoV-2:  21 December to 28 December 2021

Read the news: Omicron variant dominant in the Netherlands, 25% drop in new hospital admissions

22 December 2021| 10:00 AM

Vaccination and previous infection provide less effective protection against infection with Omicron variant

Dutch research results published today show that the protection offered by vaccination or previous infection is less effective in preventing infection with the Omicron variant of the coronavirus SARS-CoV-2 than infection with the Delta variant. Read the news.

21 December 2021| 4:00 PM

Vaccination figures: 13-19 December 2021

By Sunday 19 December, it is estimated that more than 24.6 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.3 million were second vaccinations.  

Read more about COVID-19 vaccination figures.

21 December 2021 | 4:00 PM

Weekly update on the coronavirus SARS-CoV-2:  14 December to 21 December 2021

Read the news: Downward trend in COVID-19, while vaccination and previous infection offer significantly less protection against Omicron

* The percentage of positive tests is no longer clear and unambiguous to interpret and compare over time. This is partly due to testing for confirmation after a positive self-test, and testing of returning travellers.

** A self-test is recommended for people without symptoms, for the purpose of periodic (preventive) testing when required for school or work and upon returning from holiday. Since 3 December, a self-test can also be used in the event of mild symptoms and prior to a visit. People who test positive using a self-test are advised to get tested by the Municipal Public Health Services (GGDs) to confirm the positive test result and exclude the possibility of a false positive on the self-test. It is not unlikely that not everyone will go to the GGD for a confirmation test after a positive self-test. More information on the use and results of self-tests can be found at Government.nl.

*** This is the R number for 4 December 2021. NICE data updates are provided twice a week (on Wednesdays and Saturdays). Therefore, these R numbers were calculated based on the NICE data with the data available on Saturday 18 December.

¹GGD reports to RIVMNational Institute for Public Health and the Environment between 14 December 10:01 and 21 December 10:00 as published 21 December 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

² GGD reports to RIVM between 7 December 10:01 and 14 December 10:00 as published 14 December 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

³As published 21 December 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.

⁴Not all of these reported deaths of COVID-19 patients occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.

14-12-2021 | 4:30 PM

Weekly update on the coronavirus SARS-CoV-2:  7 December tp 14 December 2021

Read the news: Slight decrease in COVID-19 hospital admissions, rising concerns due to Omicron variant 

14 December 2021| 4:30 PM

Vaccination still very effective in preventing severe COVID-19

The latest update on hospital and ICU admissions shows that COVID-19 vaccination continues to be very effective. The effectiveness of the vaccines in the last eight weeks was 89% against hospital admission and 95% against ICU admission. In the extended period from 11 July to 7 December 2021, vaccine effectiveness was 92% against hospital admission and 96% against ICU admission. Read more on the page Vaccination still very effective in preventing severe COVID-19

14 December 2021| 4:10 PM

Vaccination figures: 6 December to 12 December 2021

By Sunday 12 December, it is estimated that more than 24.5 million first and second vaccinations had been administered in the Netherlands. More than 13.2 million of those were first vaccinations, and more than 11.2 million were second vaccinations. 

It is estimated that 88.9% of all people over 18 have received at least one vaccination, and 85.8% are fully vaccinated. According to estimates, 87.2% of all people over 12 years old have now received at least one vaccination, and 84.0% are fully vaccinated. Read more about COVID-19 vaccination figures.

7-12-2021| 7:30 PM

Vaccination figures: 29 November to 5 December 2021

By Sunday 5 December, it is estimated that more than 24.5 million first and second vaccinations had been administered in the Netherlands. More than 13.2 million of those were first vaccinations, and more than 11.2 million were second vaccinations.

It is estimated that 88.8% of all people over 18 have received at least one vaccination, and 85.5% are fully vaccinated. According to estimates, 87.0% of all people over 12 years old have now received at least one vaccination, and 83.7% are fully vaccinated. Vaccination turnout and vaccination coverage increased by a maximum of 1% in a number of age groups.

07-12-2021 | 4:30 PM

Weekly update on the coronavirus SARS-CoV-2: 30 November to 7 December2021

Read the news: COVID-19 figures decreasing, but still high

7-12-2021 | 13.35

OMT advisory report, 3 December 2021

On 3 December 2021, the Outbreak Management Team (OMT) convened to consult on the COVID-19 outbreak. Among other topics, the OMT discussed the following: 

• The spread of the virus
• The effectiveness of the measures
• The added value of an extended Christmas break

Read more in the advisory report of the 132nd OMT (in Dutch). More information on the OMT can be found on the RIVMNational Institute for Public Health and the Environment pages about the Outbreak Management Team.

30 November 2021| 18:10 PM

Vaccination still very effective in preventing severe COVID-19

The latest analyses of hospital and ICU admissions show that COVID-19 vaccination continues to be very effective. In the period from 11 July to 23 November 2021, vaccine effectiveness was 93% against hospital admission and 97% against ICU admission. In the past 8 weeks, from 29 September to 23 November, vaccine effectiveness was 91% against hospital admission and 96% against ICU admission. Read more on the page Vaccination still very effective in preventing severe COVID-19.

30 November 2021| 4:30 PM

Vaccination figures: 22 to 28 November 2021

By Sunday 28 November, it is estimated that more than 24.4 million vaccinations had been administered in the Netherlands. More than 13.2 million of those were first vaccinations, and more than 11.1 million were second vaccinations. It is estimated that 88.7% of all people over 18 have received at least one vaccination, and 85.2% are fully vaccinated. According to estimates, 86.9% of all people over 12 years old have now received at least one vaccination, and 83.4% are fully vaccinated.

Go to the weekly update on COVID-19 vaccination. 

30-11-2021 | 4:30 PM

Weekly update on the coronavirus SARS-CoV-2: 23 to 30 November 2021

Read the news: Stabilisation in newly reported SARS-CoV-2 infections

23-11-2021| 4:50 PM

Vaccination figures: 15 to 21 November 2021

By Sunday 21 November, it is estimated that more than 24.3 million vaccinations had been administered in the Netherlands. More than 13.2 million of those were first vaccinations, and more than 11.1 million were second vaccinations. It is estimated that 88.5% of all people over 18 have received at least one vaccination, and 84.9% are fully vaccinated. According to estimates, 86.7% of all people over 12 years old have now received at least one vaccination, and 83.0% are fully vaccinated.

Go to the weekly update on COVID-19 vaccination. 

23-11-2021 | 4:30 PM

Weekly update on the coronavirus SARS-CoV-2: 16 to 23 November 2021

Read the news: Upward trend remains steady in all respects

23-11-2021 | 1:30 PM

OMT advisory reports - 19 November 2021

On 19 November 2021, the Outbreak Management Team (OMT) convened to consult on the COVID-19 outbreak. Among other topics, the OMT discussed the following: 

• The course of the epidemic
• Reproduction number R and forecasts for hospital and ICU admissions
• Measures
• Effectiveness of the coronavirus entry pass
• The role of self-testing in the testing landscape
• Closing time for cafés and restaurants

The OMT urgently emphasises that following the basic rules is the only way to prevent additional measures from becoming necessary this winter. The first priority is staying home and getting tested if you have symptoms, supplemented by other measures, such as staying 1.5 metres apart and wearing face masks that cover the mouth and nose in locations where distancing is not possible. Also, the OMT indicates that the use of the coronavirus entry pass is a mitigation tool intended to limit risks when opening sectors, not a preventative measure to keep the virus from spreading. 

Read more in the advisory report of the 130th OMT (in Dutch). More information on the OMT can be found on the RIVMNational Institute for Public Health and the Environment pages about the Outbreak Management Team. 

18-11-2021 | 22.46 PM

Trend continues: 7 in 10 COVID-19 patients in ICU are not vaccinated

New analyses of hospital and ICU admissions show that COVID-19 vaccination continues to be very effective. In the period from 11 July to 14 November, vaccine effectiveness was 94% against hospital admission and 97% against ICU admission. Vaccine effectiveness measured over the past eight weeks was 92% against hospital admission and 96% against ICU admission.

In the past eight weeks, the chance that a fully vaccinated person with the coronavirus SARS-CoV-2 will be admitted to hospital was 12.5 times lower than for a non-vaccinated person. The chance of ICU admission for a fully vaccinated person was 25 times lower. These results show that there are no major changes in vaccine effectiveness compared to previous analyses in early November 2021.

There are several possible explanations for why vaccine effectiveness has been slightly lower in the last 8 weeks compared to the entire period from 11 July to 14 November 2021. One possibility is that people who have recently been admitted to hospital were, on average, vaccinated longer ago than people who were admitted at an earlier point in the year. The higher infection rate in recent weeks may also explain it. 

Vaccine effectiveness against hospital admission in the age group of 70 years and older was 86% in the past eight weeks.

The new data also shows that the incidence of both hospital and ICU admissions in the age group of 50-69 years primarily increased among unvaccinated people (Figure 1). In the age group of 70 and older, the incidence of admissions also increased among fully vaccinated people, although it is still many times higher among unvaccinated people.

Figure 1. Incidence per 100,000 people of the number of COVID-19 (A) hospital admissions and (B) ICU admissions among unvaccinated, partly vaccinated and fully vaccinated people, by age group. Due to reporting delays, the data for the past few days is not yet complete.

Data used for this page comes from NICE data on hospital admissions of patients with COVID-19 admitted until 14 November 2021, enriched on 15 November 2021 with vaccination data from the central COVID-19 vaccination register (CIMS). Further details on how vaccine effectiveness is calculated can be found in the report: Effectiveness of COVID-19 vaccination against hospital and ICU admission in the Netherlands (admissions 11 July - 14 November 2021) (report in Dutch). Please note: underlying data cannot be published due to its privacy-sensitive nature.

16-11-2021| 4:00 PM

Vaccination figures: 8 to 14 November 2021

By Sunday 14 November, it is estimated that more than 24.2 million vaccinations had been administered in the Netherlands. More than 13.1 million of those were first vaccinations, and more than 11 million were second vaccinations. It is estimated that 88.3% of all people over 18 have received at least one vaccination, and 84.7% are fully vaccinated. According to estimates, 86.4% of all people over 12 years old have now received at least one vaccination, and 82.7% are fully vaccinated.

Go to the weekly update on COVID-19 vaccination.

16-11-2021 | 4:10 PM

Weekly update on the coronavirus SARS-CoV-2:  9 November to 16 November 2021

Read the news: Highest number of newly reported infections in one week, with more than 110,000 positive test results

13-11-2021 I 16:16

Total mortality significantly elevated

In the week from 28 October to 3 November 2021, total mortality in the Netherlands increased sharply (mortality reported within 2 weeks: around 97% deaths reported). A total of 3,365 deaths were reported in that week, while we would normally expect between 2,651 and 2,977 deaths per week at this time of year. Reported mortality due to laboratory-confirmed COVID-19 in the same week was 145. Mortality was slightly elevated in the age groups of 35-44 years and 55-64 years, and significantly elevated in the age groups of 65-74 years, 75-79 years, 80-84 years, 85-89 years and 90-94 years. Mortality was elevated in all combined regions.

More information provided on the page on mortality figures (in Dutch).

9-11-2021 | 4:30 PM

Weekly update on the coronavirus SARS-CoV-2:  2 November to 9 November 2021

Read the news: Nearly 77,000 people tested positive, 1,137 new COVID-19 hospital admissions

* The percentage of positive tests is no longer clear and unambiguous to interpret and compare over time. This is partly due to testing for confirmation after a positive self-test, and testing of returning travellers.

** This is the R number for 23 October 2021. NICE data updates are provided twice a week (on Wednesdays and Saturdays). Therefore, these R numbers were calculated based on the NICE data with the data available on Saturday 30 October.

¹ GGD reports to RIVMNational Institute for Public Health and the Environment between 2 November 10:01 and 9 November 10:00 as published 9 November 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

² GGD reports to RIVM between 26 October 10:01 and 2 November 10:00 as published 2 November 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

³ As published 9 November 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.

⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.

⁵ As published 9 November 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests in the context of testing for access or in order to travel.

⁶ “Other tests” includes people who are known not to have been tested after taking a self-test, and people for whom it is not known whether they were tested after taking a self-test.

⁷ For more information about the reproduction number, click here.

9-11-2021| 4:00 PM

Vaccination figures: 1 to 7 November 2021

By Sunday 7 November, it is estimated that more than 24.1 million vaccinations had been administered in the Netherlands. More than 13 million of those were first vaccinations, and more than 11 million were second vaccinations. It is estimated that 87.9% of all people over 18 have received at least one vaccination, and 84.4% are fully vaccinated. According to estimates, 85.9% of all people over 12 years old have now received at least one vaccination, and 82.4% are fully vaccinated.

Go to the weekly update on COVID-19 vaccination.

9-11-2021 | 4:30 PM

Weekly update on the coronavirus SARS-CoV-2:  2 November to 9 November 2021

Read the news: Nearly 77,000 people tested positive, 1,137 new COVID-19 hospital admissions

3 November 2021 | 2:00 PM

OMT 128 – 28 October 2021

On 28 October, the Outbreak Management Team (OMT) convened to consult on the COVID-19 outbreak. Among other topics, the OMT discussed the following: 

• The current epidemiological situation
• Reproduction number and prediction hospital and ICU admissions
• Coronavirus measures 
• Implementation of coronavirus entry pass in the workplace and healthcare
• Education
• Source and contact tracing (BCO in Dutch)

The advisory report from the OMT can be found on the website of the Dutch government (in Dutch). More information on the OMT can be found on the page about the Outbreak Management Team.

2 November 2021| 4:00 PM

Vaccination figures: 25 to 31 October 2021

By Sunday 31 October, it is estimated that about 24 million vaccinations had been administered in the Netherlands. More than 13 million of those were first vaccinations and nearly 11 million were second vaccinations. It is estimated that 87.5% of all people over 18 have received at least one vaccination and 84.1% are fully vaccinated. 85.4% of all people over 12 years old have received at least one vaccination, and 82.1% are fully vaccinated. 

Go to the weekly update on COVID-19 vaccination. 

2-11-2021 | 4:30 PM

Weekly update on the coronavirus SARS-CoV-2:  26 October to 2 November 2021

Read the news: Over 30% more COVID-19 hospital admissions

26 October 2021| 4:00 PM

Vaccination figures: 18 to 24 October 2021

By Sunday 24 October, it is estimated that more than 23.9 million vaccinations had been administered in the Netherlands. Nearly 13 million of those were first vaccinations, and more than 10.9 million were second vaccinations. It is estimated that 87.2% of all people over 18 have received at least one vaccination. 85.2% of all people over 12 years old have received at least one vaccination, and 81.7% are fully vaccinated. 

Go to the weekly update on COVID-19 vaccination.

26-10-2021 | 4:10 PM

Weekly update on the coronavirus SARS-CoV-2:  19 to 26 October 2021

Read the news: Number of positive COVID-19 tests more than doubled within two weeks

19 October 2021 | 4:30 PM

Graph of different variants no longer updated

The national pathogen surveillance shows that the relative prevalence of the different variants has been very stable for some time now; over 99.9% of the samples now involve the Delta variant. As a result, the graph tracking the different variants no longer displays any changes, and will not be updated for the time being. Pathogen surveillance will obviously continue and the table with the results of analysed samples and the downloadable pdf are updated every week. The graph will be updated again to reflect any future changes in variant prevalence.

19-10-2021 | 4:10 PM

Weekly update on the coronavirus SARS-CoV-2:  12 to 19 October 2021

Read the news: Upward trend in reported SARS-CoV-2 infections continues

12 October 2021| 4:45 PM

Vaccination figures: 4 to 10 October 2021

By Sunday 10 October, it is estimated that more than 23.7 million vaccinations had been administered in the Netherlands. More than 12.9 million of those were first vaccinations, and more than 10.8 million were second vaccinations. It is estimated that 86.9% of all people over 18 have received at least one vaccination, and 83.2% are fully vaccinated. Looking at all people aged 12 years and older, 84.7% have received at least one vaccination, and 80.9% are fully vaccinated.

Go to the weekly update on COVID-19 vaccination.

19 October 2021| 4:00 PM

Vaccination figures: 11 to 17 October 2021

By Sunday 17 October, it is estimated that more than 23.8 million vaccinations had been administered in the Netherlands. More than 12.9 million of those were first vaccinations, and more than 10.8 million were second vaccinations. It is estimated that 87.1% of all people over 18 have received at least one vaccination, and 83.5% are fully vaccinated. Looking at all people aged 12 years and older, 84.9% have received at least one vaccination, and 81.4% are fully vaccinated.

Go to the weekly update on COVID-19 vaccination.

12-10-2021 | 4:45 PM

Weekly update on the coronavirus SARS-CoV-2:  5 to 12 October 2021

Read the news: Expected autumn increase in SARS-CoV-2 appears to have started

05 October 2021| 4:45 PM

Vaccination figures: 26 September to 3 October 2021

By Sunday 3 October, it is estimated that more than 23.6 million vaccinations had been administered in the Netherlands. More than 12.8 million of those were first vaccinations, and more than 10.7 million were second vaccinations. It is estimated that 86.7% of all people over 18 have received at least one vaccination, and 82.9% are fully vaccinated. Looking at all people aged 12 years and older, 84.4% have received at least one vaccination, and 80.5% are fully vaccinated. 

Go to the weekly update on COVID-19 vaccination.

05-10-2021 | 3:45 PM

Weekly update on the coronavirus SARS-CoV-2:  28 September to 5 October 2021

The number of newly reported positive COVID-19 tests stabilised last week compared to the week before that (+2%). The number of positive tests per 100,000 inhabitants rose from 71 to 72. Fewer people (-7%) were tested for COVID-19 in the GGD test lanes in the past calendar week. About the same number of new COVID-19 patients were admitted to hospital last week, and fewer patients were admitted to ICU (-12%). The reproduction number based on the number of positive COVID-19 tests was 0.96.

More than 23 million vaccinations have been given by now.

28 September 2021| 4:15 PM

Vaccination figures: 20 to 26 September 2021

By Sunday 26 September, it is estimated that more than 23.5 million vaccinations had been administered in the Netherlands. More than 12.8 million of those were first vaccinations, and more than 10.7 million were second vaccinations. It is estimated that 86.3% of all people over 18 have received a first vaccination, and 82.4% are fully vaccinated. Looking at all people over 12 years old, 84.0% have received a first vaccination, and 80.0% are fully vaccinated. 

Go to the weekly update on COVID-19 vaccination.

28-09-2021 | 4:00 PM

Weekly update on the coronavirus SARS-CoV-2:  21 - 28 September 2021

The number of newly reported positive COVID-19 tests decreased last week compared to the week before that (-12%). That brought the number of positive tests per 100,000 inhabitants from 79 to 71. Fewer people (-9%) were tested by the GGD in the past calendar week. Last week, fewer new COVID-19 patients were admitted to hospital (-30%) and ICU (-18%) compared to the week before. The reproduction number based on the number of positive COVID-19 tests is still below 1.

More than 23 million vaccinations have been given by now.

21 September 2021| 6:00 PM

Vaccination figures: 13–19 September 2021

By Sunday 19 September, it is estimated that 23.4 million vaccinations had been administered in the Netherlands. More than 12.7 million of those were first vaccinations, and more than 10.6 million were second vaccinations. It is estimated that 86.0% of all people over 18 have received a first vaccination, and 82.1% are fully vaccinated. Looking at all people over 12 years old, 83.5% have received a first vaccination, and 79.6% are fully vaccinated.

More vaccinations were administered in the past week than in the previous few weeks, especially in the younger age groups. As a result, turnout for the first vaccination rose more sharply than in recent weeks.

Go to the weekly update on COVID-19 vaccination.

21 September 2021 | 3:20 PM

Weekly update on the coronavirus SARS-CoV-2:  14 - 21 September 2021

The number of newly reported positive COVID-19 tests decreased last week compared to the week before that (-11%). That brings the number of positive COVID-19 tests per 100,000 inhabitants from 104 to 94. More people (+9%) were tested for COVID-19 in the GGD test lanes in the past calendar week. Fewer new COVID-19 patients were admitted to hospital (-15%) and ICU (-20%) compared to the week before.The reproduction number based on the number of positive COVID-19 tests is still at 1.

More than 23 million vaccinations have been given by now.

15 September 2021 | 2:44 PM

OMT advisory reports on 3 and 10 September 2021

On 3 September and on 10 September, the Outbreak Management Team (OMT) convened to consult on the COVID-19 outbreak. Among other topics, the OMT discussed the following: 

• Epidemiological situation;
• Reproduction number, relative transmissibility of variants;
• Breath test;
• Protection of vulnerable groups;
• Scenarios for discontinuing measures;
• Practical tests in field labs;
• Face masks in public transport;
• Source and contact tracing.

The advisory reports of the 125th OMT COVID-19 and the 126th OMT COVID-19 have been posted on the website of the Dutch government. In this video, Aura Timen explains why the OMT has advised against discontinuing all measures at once (in Dutch).

More information on the OMT can be found on the pages about the Outbreak Management Team. 

14 September 2021| 6:30 PM

Vaccination figures: 6 January – 12 September 2021

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news:  People who had one jab after having COVID-19 now included in vaccination coverage figures for full vaccination 

14-09-2021 | 3:40 PM

Weekly update on the coronavirus SARS-CoV-2:  7 - 14 September 2021

The number of newly reported positive COVID-19 tests decreased last week compared to the week before that (-11%). That brings the number of positive COVID-19 tests per 100,000 inhabitants from 104 to 94. More people (+9%) were tested for COVID-19 in the GGD test lanes in the past calendar week. Fewer new COVID-19 patients were admitted to hospital (-15%) and ICU (-20%) compared to the week before.The reproduction number based on the number of positive COVID-19 tests is still at 1.

More than 23 million vaccinations have been given by now.

7 September 2021| 4:23 PM

Vaccination figures: 30 August – 5 September 2021

By Sunday 5 September, it is estimated that more than 23.1 million vaccinations had been administered in the Netherlands. More than 12.6 million of those were first vaccinations, and more than 10.5 million were second vaccinations. It is estimated that 85.4% of all people over 18 have received a first vaccination by now, and 77.1% are fully vaccinated. Looking at all people over 12 years old, 83.1% have received a first vaccination, and 74.3% are fully vaccinated.

Go to the weekly update on COVID-19 vaccination.

07 September 2021 | 3:00 PM

Weekly update on the coronavirus SARS-CoV-2: 31 August  - 7 September 2021

The number of newly reported positive COVID-19 tests stabilised last week compared to the week before that (+2%). The number of positive COVID-19 tests per 100,000 inhabitants rose slightly, from 102 to 104. More people (+25%) were tested for COVID-19 in the GGD test lanes in the past calendar week. Fewer new COVID-19 patients were admitted to hospital (-9%) and ICU (-10%) last week. The reproduction number based on the number of positive COVID-19 tests is still at 1.

More than 23 million vaccinations have been given by now.

* The percentage of positive tests is no longer clear and unambiguous to interpret and compare over time. This is partly due to a recent increase in testing at walk-in test sites not requiring an appointment for students during introduction weeks, testing of returning travellers, and testing for confirmation after a positive self-test.

** This is the R number for 21 August 2021. NICE data updates are provided twice a week (on Wednesdays and Saturdays). Therefore, these R numbers were calculated based on the NICE data with the data available on Saturday 4 September.

31 August 2021 | 4:30 PM

Pharmacovigilance Centre Lareb: biweekly report

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 126,594 reports by 29 August 2021, involving 656,511 possible side-effects. Most of the reported symptoms are in line with side-effects that were already known, such as headache, muscle pain and reactions at the injection site. Since the start of the vaccination campaign, Lareb has received a total of 514 reports regarding deaths shortly after receiving the COVID-19 vaccinations. Most of the reports involved the Pfizer/BioNTech vaccine. It is the COVID-19 vaccine that has been used most frequently, and is also the vaccine that is mainly given to the elderly. 

The overview of adverse events following immunisation published every two weeks on the Lareb website shows that there have now been 42 reports of blood clots in combination with low platelets after vaccination (35 after AstraZeneca, 7 after Janssen). In 21 of these reported cases, it is almost certain that the rare side effect designated as Thrombosis with Thrombocytopenia Syndrome (TTS) was involved.

31 August 2021 | 4:23 PM

Weekly vaccination figures: 23–29 August 2021

By Sunday 29 August, it is estimated that more than 22.9 million vaccinations had been administered in the Netherlands. More than 12.5 million of those were first vaccinations, and more than 10.3 million were second vaccinations. It is estimated that 85.2% of all people over 18 have received a first vaccination by now, and 76.5% are fully vaccinated. Looking at all people over 12 years old, 82.8% have received a first vaccination, and 73.3% are fully vaccinated. 

Go to the weekly update on COVID-19 vaccination.

31-08-2021 | 3:15 PM

Weekly update on the coronavirus SARS-CoV-2: 24 - 31 August 2021

The number of newly reported positive COVID-19 tests stabilised last week compared to the week before that (+2%). The number of positive COVID-19 tests per 100,000 inhabitants rose slightly, from 100 to 102. The number of people who were tested by the Municipal Public Health Services (GGDs) increased by 12% in the past calendar week. The number of new people with COVID-19 admitted to hospital also stabilised in the past week (-2.6%). The same number of people with COVID-19 were admitted to ICU compared to the week before. The reproduction number based on the number of positive COVID-19 tests is still at 1.

Nearly 23 million vaccinations have been given by now.

* The percentage of positive tests is no longer clear and unambiguous to interpret and compare over time. This is partly due to a recent increase in testing at walk-in test sites not requiring an appointment for students during introduction weeks, testing of returning travellers, and testing for confirmation after a positive self-test.

** This is the R number for 14 August 2021. NICE data updates are provided twice a week (on Wednesdays and Saturdays). Therefore, these R numbers were calculated based on the NICE data with the data available on Saturday 28 August.

24 August 2021 | 5:37 PM

COVID-19 vaccination figures:  16 - 22 August 2021

By Sunday 22 August, it is estimated that more than 22.6 million vaccinations had been administered in the Netherlands. More than 12.5 million of those were first vaccinations, and more than 10.1 million were second vaccinations. It is estimated that 84.9% of all people over 18 have received a first vaccination by now, and 75.7% are fully vaccinated. This week, these figures are also available for everyone over the age of 12. 82.4% of all people over 12 years old have received a first vaccination, and 72.0% are fully vaccinated. 

Go to the weekly update on COVID-19 vaccination.

24-08-2021 | 4:15 PM

Weekly update on the coronavirus SARS-CoV-2: 17 – 24 August 2021

5% more positive COVID-19 tests were reported last week compared to the week before. 7% more people were tested in the test lanes of the Municipal Public Health Services (GGDs) during the last calendar week than the week before. The number of positive COVID-19 tests per 100,000 inhabitants increased compared to the previous week, rising from 98 to 100. The number of new patients that had to be admitted to hospital with COVID-19 decreased by 12%. The same number of new COVID-19 patients were admitted to ICU compared to the week before. The reproduction number based on the number of positive COVID-19 tests is 1. 

More than 22 million vaccinations have been given by now. 

Significant majority of people testing positive for COVID-19 have not been vaccinated

During the past six calendar weeks, 368,060 people received a positive test result. The vaccination status of 305,682 (83%) of those people is known at this time. Of the people who tested positive and whose vaccination status is known, 66% were were not vaccinated (or not yet), 18% were partly vaccinated, and 16% were fully vaccinated. The majority of the people who tested positive in the age groups under 40 years old were unvaccinated. For more information on the vaccination status of reported people who tested positive per 100,000 inhabitants, by age group, see the Graphs page.

17 August 2021 | 2:51 PM

Pharmacovigilance Centre Lareb: biweekly report

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 118,998 reports by 15 August 2021, involving 622,163 possible side-effects. Most of the reported symptoms are in line with side-effects that were already known, such as headache, muscle pain and reactions at the injection site. Since the start of the vaccination campaign, Lareb has received a total of 509 reports regarding deaths shortly after receiving the COVID-19 vaccinations. Most of the reports involved the Pfizer/BioNTech vaccine. It is the COVID-19 vaccine that has been used most frequently, and is also the vaccine that is mainly given to the elderly.

The biweekly Lareb update stated there have now been 41 reports of blood clots in combination with low platelets after vaccination (34 after AstraZeneca, 7 after Janssen). In 21 of these reported cases, it is almost certain that the rare side effect designated as Thrombosis with Thrombocytopenia Syndrome (TTS) was involved.

17 August 2021 | 5:04 PM

COVID-19 vaccination figures:  9 - 15 August 2021

By Sunday 15 July, it is estimated that 22.3 million COVID-19 vaccinations had been administered in the Netherlands. More than 12.4 million of those were first vaccinations, and more than 9.9 million were second vaccinations. It is estimated that nearly 75% of all people over 18 have received full vaccination by now. About 85% have received their first vaccination. 

Go to the weekly update on COVID-19 vaccination.

17-08-2021 | 15:20 PM

Weekly update on the coronavirus SARS-CoV-2: 11 – 17 August 2021

8% fewer positive COVID-19 tests were reported last week compared to the week before. The number of positive COVID-19 tests per 100,000 inhabitants decreased compared to the previous week, dropping from 103 to 98. The number of new patients that had to be admitted to hospital with COVID-19 decreased slightly, dropping by 6%. 26% fewer new COVID-19 patients were admitted to ICU compared to the week before.  The reproduction number based on the number of positive COVID-19 tests is below 1.

More than 22 million vaccinations have been given by now.

* NICE data updates are provided twice a week (on Wednesdays and Saturdays). R numbers based on that data are therefore now calculated with the latest complete data: 31 July 2021.

More than 22 million vaccinations have been given by now. 

17 August 2021 | 2:51 PM

Pharmacovigilance Centre Lareb: biweekly report

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 118,998 reports by 15 August 2021, involving 622,163 possible side-effects. Most of the reported symptoms are in line with side-effects that were already known, such as headache, muscle pain and reactions at the injection site. Since the start of the vaccination campaign, Lareb has received a total of 509 reports regarding deaths shortly after receiving the COVID-19 vaccinations. Most of the reports involved the Pfizer/BioNTech vaccine. It is the COVID-19 vaccine that has been used most frequently, and is also the vaccine that is mainly given to the elderly.

The biweekly Lareb update stated there have now been 41 reports of blood clots in combination with low platelets after vaccination (34 after AstraZeneca, 7 after Janssen). In 21 of these reported cases, it is almost certain that the rare side effect designated as Thrombosis with Thrombocytopenia Syndrome (TTS) was involved.

10-08-2021 | 15:35 PM

Weekly update on the coronavirus SARS-CoV-2: 4 – 10 August 2021

14% fewer positive COVID-19 tests were reported last week compared to the week before. The number of positive COVID-19 tests per 100,000 inhabitants decreased compared to the previous week, dropping from 121 to 103. The number of newly reported infections decreased in all age groups. The number of reports decreased in nearly all regions. The number of new patients that were admitted to hospital with COVID-19 decreased by 27%. 13% fewer new COVID-19 patients were admitted to ICU compared to the week before. The reproduction number based on the number of positive COVID-19 tests is below 1.

More than 21 million vaccinations have been given by now.

* This percentage of positive tests does not include the tests that were taken in the context of travel. In order to obtain a test result for travel purposes, 20,800 people were tested in the test lanes of the Municipal Public Health Services (GGDs) and 301,522 people were tested at commercial test sites. In total, 0.5% of these travellers tested positive.

** NICE data updates are provided twice a week (on Wednesdays and Saturdays). R numbers based on that data are therefore now calculated with the latest complete data: 26 July 2021.

10 August 2021 | 5:45 PM

COVID-19 vaccination figures: 2-8 August 2021

By Sunday 8 August, it is estimated that 21.6 million COVID-19 vaccinations had been administered in the Netherlands. More than 12.3 million of those were first vaccinations, and more than 9.2 million were second vaccinations. It is estimated that more than 71% of all people over 18 have been fully vaccinated by now. Based on registered vaccinations, more than 84% of all people over 51 have been fully vaccinated, rising to 91% of all people aged 76-80 years.

Go to the weekly update on COVID-19 vaccination.

4 August 2021 | 12:40 PM

COVID-19 vaccination figures: 6 January – 3 August 2021

Read the news: Nearly 85% of people aged 18 and over have had at least one vaccination

Go to the weekly update on COVID-19 vaccination.

03-08-2021 | 16:00 PM

Weekly update: 27 July – 3 August 2021

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Hospital admissions appear to have peaked, 44% fewer positive COVID-19 tests

* This percentage of positive tests does NOT include the tests that were taken in the context of travel. In order to obtain a test result for travel purposes, 26,470 people were tested in the GGD lanes and 383,544 people were tested at commercial test sites. In total, 0,5% of these travellers tested positive. 

**NICE data updates are provided twice a week (on Wednesdays and Saturdays). From now on, the R numbers based on that data will therefore be calculated with the latest complete data: 17 July 2021.

3 August 2021 | 14:33 PM

Pharmacovigilance Centre Lareb: biweekly report

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 112,677 reports by 1 August 2021, involving 591,589 possible side-effects. Most of the reported symptoms are in line with side-effects that were already known, such as headache, muscle pain and reactions at the injection site. Since the start of the vaccination campaign, Lareb has received a total of 491 reports regarding deaths shortly after receiving the COVID-19 vaccinations. Most of the reports involved the Pfizer/BioNTech vaccine. It is the COVID-19 vaccine that has been used most frequently, and is also the vaccine that is mainly given to the elderly.

A news item on the Lareb website announced there have now been 40 reports of blood clots in combination with low platelets after vaccination (33 after AstraZeneca, 7 after Janssen). In 21 of these reported cases, it is almost certain that the rare side effect designated as Thrombosis with Thrombocytopenia Syndrome (TTS) was involved.

3 August 2021 | 13:30 PM

OMT 122 - 3 August 2021

On 3 August, the Outbreak Management Team (OMT) met to advise on the COVID-19 outbreak in the Netherlands. Among other things, the OMT discussed the following topics: 

• The current epidemiological situation;
• Vaccine effectiveness of the Janssen vaccine
• One-day events without assigned seating
• Bill on authority to close public and private locations

The advisory report by the OMT can be found on Government.nl (in Dutch). More information is available on the OMT page of the RIVM National Institute for Public Health and the Environment   website.

28 July 2021 | 9:00 AM

OMT 121 - 23 July 2021

On 23 July, the Outbreak Management Team (OMT) met to advise on the COVID-19 outbreak in the Netherlands. Among other things, the OMT discussed the following topics: 

• The current epidemiological situation;
• The different virus variants;
• Travel advisories and quarantine for travellers;
• Ventilation

The advisory report by the OMT can be found on Government.nl (in Dutch). More information is available on the OMT page of the RIVM National Institute for Public Health and the Environment   website.

27 July 2021 | 16:20 PM

Vaccination figures: 19 to 25 July 2021

By Sunday 25 July, it is estimated that more than 20.1 million vaccinations had been administered in the Netherlands. More than 12.2 million of those were first vaccinations, and nearly 8 million were second vaccinations. In the age group of 30-39 years, more than 1.4 million people have now received their first vaccination. More than 80% of all people over 50 have been fully vaccinated, rising to 88% of all people aged 80-89 years.

Go to the weekly update on COVID-19 vaccination.

27-07-2021 | 15:20 PM

Weekly update: 20 July – 27 July 2021

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: More hospital admissions, decrease in positive COVID-19 tests.

* This percentage of positive tests does NOT include the tests that were taken in the context of travel. In order to obtain a test result for travel purposes, more than 35,000 people were tested in the GGD lanes and more than 414,000 people were tested at commercial test sites. In total, 0,7% of these travellers tested positive. 

**NICE data updates are provided twice a week (on Wednesdays and Saturdays). From now on, the R numbers based on that data will therefore be calculated with the latest complete data: 5 July 2021.

20 July 2021 | 16:35 PM

Vaccination figures: 6 January – 18 July 2021

Read the news: Vaccination turnout for people aged 25-44: 66% vaccinated at least once

Go to the weekly update on COVID-19 vaccination.

20-07-2021 | 16:30 PM

Weekly update: 13 July – 20 July 2021

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Increase in hospital admissions, cautious stabilisation in positive COVID-19 tests

*This percentage of positive tests includes the tests that were taken in the context of travel. Excluding the number of tests taken in the context of travel, the percentage of positive tests is 15.3%. 

**NICE data updates are provided twice a week (on Wednesdays and Saturdays). From now on, the R numbers based on that data will therefore be calculated with the latest complete data: 5 July 2021.

13 July 2021 | 17:40 PM

Vaccination figures: 6 January – 11 July 2021

Read the news: Vaccination coverage is rising, while data is increasingly comprehensive

Go to the weekly update on COVID-19 vaccination.

13-07-2021 | 16:10 PM

Weekly update: 6 July – 13 July 2021

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Number of people who tested positive increases sixfold, reproduction number rises to 2.17

*This percentage of positive tests includes the tests that were taken in the context of travel. Excluding the number of tests taken in the context of travel, the percentage of positive tests is 15.9%. 

**NICE data updates are provided twice a week (on Wednesdays and Saturdays). From now on, the R numbers based on that data will therefore be calculated with the latest complete data: 26 June 2021.

***Last week was the last time that the number of contagious people was reported for the time being, since this figure is based on the number of hospital admissions. In this phase of the epidemic, when more and more people are vaccinated, and therefore fewer people are admitted to hospital, the number of infections in the general population is increasingly out of sync with the number of hospital admissions. That is why the number of contagious people is no longer calculated.

06 July 2021 | 17:00 PM

Vaccination figures: 28 June – 4 July 2021

By Sunday 4 July, it is estimated that more than 16.7 million vaccinations had been administered in the Netherlands. More than 10.8 million of those were first vaccinations, and over 5.8 million were second vaccinations. The daily number of vaccinations administered is posted on the Coronavirus Dashboard

Go to the weekly update on COVID-19 vaccination.

06-07-2021 | 16:10 PM

Weekly update: 30 June – 6 July 2021

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Number of positive COVID-19 tests doubled in one week

*NICE data updates are provided twice a week (on Wednesdays and Saturdays). From now on, the R numbers based on that data will therefore be calculated with the latest complete data: 19 June 2021

** For the time being, this is the last week that the number of contagious people will be reported, since this figure is based on the number of hospital admissions. In this phase of the epidemic, when more and more people are vaccinated, and therefore fewer people are admitted to hospital, the number of infections in the general population is increasingly out of sync with the number of hospital admissions. For that reason, the number of hospital admissions will no longer be used to calculate the number of contagious people.

06-07-2021 | 12:40 PM

Pharmacovigilance Centre Lareb: biweekly report

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 93,453 reports by 4 July 2021, involving 498,983 possible side-effects. Most of the reported symptoms are in line with side-effects that were already known, such as headache, muscle pain and reactions at the injection site. Since the start of the vaccination campaign, Lareb has received a total of 448 reports regarding deaths shortly after receiving the COVID-19 vaccinations. Most of the reports involved the Pfizer/BioNTech vaccine. It is the COVID-19 vaccine that has been used most frequently, and is also the vaccine that is mainly given to the elderly. A news item on the Lareb website announced there have now been 34 reports of blood clots in combination with low platelets after vaccination (32 after AstraZeneca, 2 after Janssen). In 18 of these reported cases, it is almost certain that the rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS) was involved.  

05-07-2021 | 13:15 PM

Lareb: reported deaths following COVID-19 vaccination

Pharmacovigilance Centre Lareb published an overview today regarding the reported deaths in the first 14 weeks of the vaccination campaign (up to 15 April 2021). The overview does not suggest any pattern of symptoms that indicate severe side-effects leading to death, other than the previously identified rare side-effect of thrombosis with thrombocytopenia syndrome (TTS). In some cases, side-effects may have contributed to exacerbation of an already vulnerable health situation.

29-06-2021 | 14:50 PM

Weekly update: 23 – 29 June 2021

26% fewer positive COVID-19 tests were reported last week compared to the week before. The number of positive COVID-19 tests per 100,000 inhabitants decreased compared to the previous week, dropping from 34 to 25. The number of new patients that had to be admitted to hospital with COVID-19 decreased by 52%. 48% fewer new COVID-19 patients were admitted to ICU compared to the week before. The reproduction numbers based on  positive COVID-19 tests, hospital admissions and ICU admissions are still below 1.

More than 15 million vaccinations have been given by now.

22 June 2021 | 16:00 PM

Vaccination figures: 14 to 20 June 2021

By Sunday 20 June, it is estimated that nearly 13.9 million vaccinations had been administered in the Netherlands. More than 8.6 million of those were first vaccinations, and 4.4 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard

Go to the weekly update on COVID-19 vaccination.

22-06-2021 | 14:50 PM

Weekly update: 16 – 22 June 2021

36% fewer positive COVID-19 tests were reported last week compared to the week before. The number of positive COVID-19 tests per 100,000 inhabitants decreased compared to the previous week, dropping from 53 to 34. The number of new patients that had to be admitted to hospital with COVID-19 decreased by 35%. 26% fewer new COVID-19 patients were admitted to ICU compared to the week before. The reproduction numbers based on positive COVID-19 tests, hospital admissions and ICU admissions are below 1.

Nearly 13,9 million vaccinations have been given by now. At this point, people born in 2003 or before can make a vaccination appointment

22 June 2021 | 12:35 PM

Pharmacovigilance Centre Lareb: biweekly report 

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 81,480 reports by 20 June, involving 440,266 possible side-effects. Most of the reported symptoms are in line with side-effects that were already known, such as headache, muscle pain and reactions at the injection site. Since the start of the vaccination campaign, Lareb has received a total of 409 reports regarding deaths shortly after receiving the COVID-19 vaccinations. Most of the reports involved the Pfizer/BioNTech vaccine. It is the COVID-19 vaccine that has been used most frequently, and is also the vaccine that is mainly given to the elderly. A news item on their website announced there have now been 10 reports of myocarditis (inflammation of the heart muscle) and 22 reports of pericarditis (inflammation of the outer lining of the heart) after vaccination. There has been one report of systemic capillary leak syndrome in the context of the Janssen vaccine. 

22 June 2021 | 12:05 PM

Researching the risk of COVID-19 during air travel

RIVM and the Netherlands Aerospace Centre (Royal NLR) conducted a study on the risk that a person will become ill by breathing in the coronavirus SARS-CoV-2 while on board an aircraft. The current measures, such as staying home if you have symptoms and showing a negative test and/or health statement before boarding, reduce the risk that someone who has the virus will board a plane. If someone who has the virus does board, the risk of contracting COVID-19 is relatively low for passengers in the seven rows around the contagious passenger. The risk is lower than in an indoor space with similar dimensions that is not ventilated, for example. The risk decreases proportionate to the distance from the contagious passenger. This study did not look at transmission of the virus via direct contact and surfaces. 

RIVM estimated the risk based on measurements and computer simulations provided by the NLR. Various scenarios were run using mannequins in three types of aircraft cabins with seven rows. A ‘contagious passenger’ was seated in the middle row, exhaling artificial saliva that did not contain the actual virus. Measurements in the cabins showed how many droplets reached the mannequins. 

Do you have symptoms? Stay home and get tested
Measures to reduce the risk that an infected passenger might board an aircraft are still important. For travellers: Do you have symptoms? Stay home and get tested. If you test positive, go into home isolation. 

Go to the NLR news item (in Dutch) and report (in English)

15 June 2021 | 16:15 PM

Vaccination figures: 7 to 13 June 2021

By Sunday 13 June, it is estimated that more than 12.4 million vaccinations had been administered in the Netherlands. Almost 8.3 million of those were first vaccinations, and 4 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.

Go to the weekly update on COVID-19 vaccination.

15-06-2021 | 15:15 PM

The weekly update for 9-15 June is online

In the past week, there has been an increase in young people who tested positive for COVID-19 after returning from a holiday in another country. Young people between the ages of 17 and 24 who are returning from holiday in Spain and Portugal are urged to take a PCR test, even if they do not have symptoms.

Weekly update: 9 – 15 June 2021

38% fewer positive COVID-19 tests were reported last week compared to the week before. The number of positive COVID-19 tests per 100,000 inhabitants decreased compared to the previous week, dropping from 84 to 53. The number of new patients that had to be admitted to hospital with COVID-19 decreased by 44%. 19% fewer new COVID-19 patients were admitted to ICU compared to the week before. The reproduction numbers based on positive COVID-19 tests, hospital admissions and ICU admissions are below 1.

More than 12 million vaccinations have been given by now. At this point, people born in 1996 or before can make a vaccination appointment

8 June 2021 | 17:50 PM

Vaccination figures: 31 May to 6 June 2021

By Sunday 6 June, it is estimated that more than 10.7 million vaccinations had been administered in the Netherlands. More than 7.3 million of those were first vaccinations, and 3.4 million were second vaccinations.  The daily number of doses administered is posted on the Coronavirus Dashboard

Go to the weekly update on COVID-19 vaccination.

08-06-2021 | 15:15 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Downward trend continues in all areas

Weekly Update 2 June to 8 June 2021

8 June 2021 I 12:25

Pharmacovigilance Centre Lareb: biweekly report 

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 69,800 reports by 6 June, involving 384,558 possible side-effects. Most of the reported symptoms are in line with side-effects that were already known, such as headache, muscle pain and reactions at the injection site. Since the start of the vaccination campaign, Lareb has received a total of 381 reports regarding deaths shortly after receiving the COVID-19 vaccinations. Most of the reports involved the Pfizer/BioNTech vaccine. It is the COVID-19 vaccine that has been used most frequently, and is also the vaccine that is mainly given to the elderly. Lareb announced in a news item that a number of side-effects may have contributed to deterioration of a vulnerable health situation or undetected underlying health problems, possibly related to advanced age. RIVM National Institute for Public Health and the Environment   is monitoring the developments closely. 

1 June 2021 I 17:00

Vaccination figures: 24 to 30 May 2021

By Sunday 30 May, it is estimated that more than 9.3 million vaccinations had been administered in the Netherlands. More than 6.5 million of those were first vaccinations, and 2.8 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard. The actual number of doses administered is about 78,000 higher than presented in the current overview. This is due to the data registered by the Municipal Public Health Services (GGDs) regarding the Janssen vaccine, which has been rolled out for vaccination since 28 May; this data has not yet been processed. 

Go to the weekly update on COVID-19 vaccination.

01-06-2021 | 15:15 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Effects of COVID-19 vaccination becoming increasingly visible

Weekly Update 26 May to 1 June 2021

29 May 2021 I 13:32 PM

Model study on effectiveness of the CoronaMelder app

In its first few months, the CoronaMelder app made a positive but minor contribution to controlling the coronavirus SARS-CoV-2. This is the conclusion of an RIVM evaluation of the effect of CoronaMelder in combination with testing and standard source and contact tracing.

The effect of the app between 1 December 2020 and 31 March 2021 was estimated using modelling. From 1 December 2020 to 31 March 2021, 7514 people tested positive for COVID-19 after a notification from the CoronaMelder app. It is estimated that these notifications prevented over 15,000 infections. The R number (the average number of new infections caused by an infected person) was 12.7% lower due to the combination of testing, standard source and contact tracing and the CoronaMelder app. The app contributed 0.3% to this percentage.

26 May I 15:05 PM

Pharmacovigilance Centre Lareb: biweekly report

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 60,301 reports by 24 May, involving 338,418 possible side-effects. Most of the reported symptoms are in line with side-effects that were already known, such as headache, muscle pain and reactions at the injection site.

Since the start of the vaccination campaign, Lareb has received a total of 351 reports regarding deaths shortly after receiving the COVID-19 vaccinations. Most of the reports involved the Pfizer/BioNTech vaccine. It is the COVID-19 vaccine that has been used most frequently, and is also the vaccine that is mainly given to the elderly. Lareb announced in a news item that they were all in vulnerable health due to various serious underlying diseases and/or advanced age. RIVM is monitoring the developments closely.

25 May 2021 | 16:15 PM

Vaccination figures: 17 to 23 May 2021

By Sunday 23 May, it is estimated that more than 8.4 million vaccinations had been administered in the Netherlands. More than 6.1 million of those were first vaccinations, and 2.3 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard. 

Go to the weekly update on COVID-19 vaccination.

18 May 2021 | 16:15 PM

Vaccination figures: 10 to 16 May 2021

By Sunday 16 May, it is estimated that more than 7.4 million vaccinations had been administered in the Netherlands. More than 5,6 million of those were first vaccinations, and nearly 1.8 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard

Go to the weekly update on COVID-19 vaccination.

18-05-2021 | 16:15 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Downward trend continues.

Weekly Update 11 to 18 May 2021

11 May 2021 | 16:30 PM

Vaccination figures: 3 to 9 May 2021

By Sunday 9 May, it is estimated that more than 6.4 million vaccinations had been administered in the Netherlands. Almost 5 million of those were first vaccinations, and over 1.4 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard

Go to the weekly update on COVID-19 vaccination.

11 May 2021 | 13:32 PM

Pharmacovigilance Centre Lareb: biweekly report 

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 49,850 reports by 9 May, involving 287,034 possible side-effects. Most of the reported symptoms are in line with side-effects that were already known.

Since the start of the vaccination campaign, Lareb has received a total of 320 reports regarding deaths shortly after receiving the COVID-19 vaccinations. Most of the reports involved the Pfizer/BioNTech vaccine. It is the COVID-19 vaccine that has been used most frequently, and is also the vaccine that is mainly given to the elderly. Lareb announced in a news item that they were all in vulnerable health due to various serious underlying diseases and/or advanced age. RIVM is monitoring the developments closely. 
 

11-05-2021 | 16:15 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news:  Fewer hospital admissions, but pressure on healthcare is still high

Weekly Update 5 to 11 May 2021

¹GGD reports to RIVM National Institute for Public Health and the Environment   between 4 May10:01 and 1 May 10:00 as published 11 May 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 27 April 10:01 and 4 May 10:00 as published 4 May 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 11 May 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 11 May 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

10 May 2021 | 11:10 AM

Statistics Netherlands (CBS): Mortality in week 17 higher than expected

Statistics Netherlands (CBS) reports in week 17 (26 April to 2 May inclusive) that an estimated 3,150 people have died in the Netherlands. This is approximately 250 more deaths than would normally be expected in this period, and slightly more than in the previous week (3,107). 

RIVM also keeps track of mortality figures on a weekly basis (in Dutch). In the most recent RIVM data for 22 until 28 April, total mortality in the Netherlands was elevated (mortality reported within 2 weeks - around 97% reported). A total of 3,106 deaths were reported. The reported mortality of laboratory-confirmed COVID-19 in the same week was 116. Mortality was slightly increased in the age groups 45-54 years and 80-84 years, and significantly increased in the age groups 55-64 years, 64-74 and 75-79 years. Mortality was higher in all combined regions.

04 May 2021 | 17:00 PM

Vaccination figures: 26 April to 2 May 2021

By Sunday 2 May, it is estimated that more than 5.6 million vaccinations had been administered in the Netherlands. More than 4.4 million of those were first vaccinations, and over 1.2 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard. 

Go to the weekly update on COVID-19 vaccination.

04-05-2021 | 15:57 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news:  Third wave shows major surge in hospital admissions in younger age groups

Weekly Update 27 April to 4 May 2021

 ¹GGD reports to RIVM National Institute for Public Health and the Environment   between 27 April10:01 and 4 May 10:00 as published 4 May 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 20 April 10:01 and 27 April 10:00 as published 27 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 4 May 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 4 May 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

29 April 2021 | 10:00 PM

Vaccination figures: 19 to 25 April 2021

By Sunday 25 April, it is estimated that nearly 5 million vaccinations had been administered in the Netherlands. Almost 4 million of those were first vaccinations, and over 1 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard. 

Go to the weekly update on COVID-19 vaccination.

27-04-2021 | 15:17 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news:  Increase in percentage of positive tests, stabilisation in hospital admissions  

Weekly Update 20 April to 27 April 2021

¹GGD reports to RIVM National Institute for Public Health and the Environment   between 120April10:01 and 27 April 10:00 as published 27 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 13 April 10:01 and 20 April 10:00 as published 20 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 27 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 27 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

20-04-2021 | 16:00 PM

Vaccination figures: 12 to 18 April 2021

By Sunday 18 April, it is estimated that more than 4.3 million vaccinations had been administered in the Netherlands. More than 3.4 million of those were first vaccinations, and over 900,000 were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.

Go to the weekly update on COVID-19 vaccination.

20-04-2021 | 15:10 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: One in ten tests positive.

Weekly Update 13 April to 20 April 2021

¹GGD reports to RIVM between 13 April10:01 and 20 April 10:00 as published 20 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 6 April 10:01 and 13 April 10:00 as published 13 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 20 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 20 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

13-04-2021 | 10:30 PM

Weekly update on COVID-19 vaccination: 5 to 11 April 2021

The vaccination figures published today in the RIVM report and on the Corona Dashboard are higher than in previous weeks. The news item about the vaccination figures provides further details on this increase.
By Sunday 11 April, it is estimated that nearly 3.8 million vaccinations had been administered in the Netherlands. Almost 3 million of those were first vaccinations, and over 800,000 were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.

Go to the weekly update on COVID-19 vaccination

13-04-2021 | 16:34 PM

Lareb: biweekly report 

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received and reviewed a total of 33,585 reports so far involving 197,652 possible side-effects. About 3.1 million vaccinations have been given by now. Most of the reported symptoms are in line with side-effects that were already known. Since the start of the vaccination campaign, Lareb has received a total of 225 reports regarding deaths shortly after receiving the COVID-19 vaccinations. Most of the reports involved the Pfizer/BioNTech vaccine. It is the COVID-19 vaccine that has been used most frequently, and is also the vaccine used mainly for the elderly. A news item on their website announced that existing health problems were the most likely cause of death in the majority of the reports. 

13-04-2021 | 16:25 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: More positive tests, and rising percentage of positive tests

Weekly Update 7 April to 13 April 2021

¹GGD reports to RIVM between 6 April10:01 and 13 April 10:00 as published 6 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 30 March 10:01 and 6 April 10:00 as published 6 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 13 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 13 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

The number of newly reported infections that RIVM received last week from the Municipal Public Health Services (GGDs) is not the same as the number of positive tests in that week. The number of positive tests during the week could still change in response to delayed reports. These are newly reported infections that originate from test lanes, but also from hospitals and other sources. The number of infections in a week is expected to be higher than the number of positive tests, because it is likely that not everyone who is infected will get tested.

Not everyone who tests positive for COVID-19 is referred to as a patient. That term is used for people who are so ill that they are being monitored by a doctor, or for people who became so ill that they died. Not everyone who tests positive for COVID-19 becomes that ill. Many people only develop mild symptoms, or do not notice any symptoms at all. In the past, people who tested positive for COVID-19 were sometimes referred to as patients. This term has now been updated in our communications.

09-04-2021 | 18:15 PM

Weekly update on COVID-19 vaccination: 21 March to 4 April 2021

By Sunday 4 April, it is estimated that more than 2.8 million vaccinations had been administered in the Netherlands. In week 13, the Netherlands received 326,430 doses of the Pfizer/BioNTech vaccine, 145,200 doses of the Moderna vaccine and 430,320 doses of the AstraZeneca vaccine.

Direct to weekly update on COVID-19 vaccination

06-04-2021 | 16:16 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Fewer cases, higher percentage of positive tests

Weekly Update 31March  to 6 April 2021

¹GGD reports to RIVM between 30 March 10:01 and 6 April 10:00 as published 30 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 23 March 10:01 and 30 March 10:00 as published 30 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 6 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 6 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

23-03-2021 | 16:15 PM

Weekly update on COVID-19 vaccination: 14 to 21 March 2021

By Sunday 21 March, it is estimated that nearly 1.5 million people in the Netherlands had received at least one COVID-19 vaccination, and more than 600,000 people had received their second vaccination. The 2 millionth vaccination was administered last week, on 19 March.

Direct to weekly update on COVID-19 vaccination

23-03-2021 | 16:00 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Situation growing worse in the Netherlands

Weekly Update 17 March 2021 to 23 March 2021

* Excluding results from large-scale testing in Bunschoten and Dronten.  If the localised large-scale test results from these locations are included, the percentage of positive tests in the Netherlands is 7.6%. Not including the results from large-scale testing at these locations, the percentage of positive tests in the Netherlands is 8.1%.

¹GGD reports to RIVM between 16 March 10:01 and 23 March 10:00 as published 23 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 9 March 10:01 and 16 March 10:00 as published 16 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 23 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 23 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

16-03-2021 | 16:25 PM

Weekly update on COVID-19 vaccination: 8 to 14 March 2021

By Sunday 14 March, it is estimated that nearly 1.4 million people in the Netherlands had received at least one COVID-19 vaccination, and nearly 500,000 people had received their second vaccination.

Direct to weekly update on COVID-19 vaccination

16-03-2021 | 16:00 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Situation in the Netherlands remains concerning

Weekly Update 10 March 2021 to 16 March 2021

* Excluding results from large-scale testing in Bunschoten and Dronten.  If the localised large-scale test results from these locations are included, the percentage of positive tests in the Netherlands is 7.6%. Not including the results from large-scale testing at these locations, the percentage of positive tests in the Netherlands is 7.7%.

¹GGD reports to RIVM between 9 March 10:01 and 16 March 10:00 as published 16 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 2 March 10:01 and 9 March 10:00 as published 9 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 16 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 16 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

16-03-2021 | 14.00 uur

Lareb: biweekly report 

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received and reviewed a total of 10,887 reports so far involving 57,391 possible side-effects. Nearly 1.9 million vaccinations have been given by now. Most of the reported symptoms are in line with side-effects that were already known. Since the start of the vaccination campaign, Lareb has received a total of 138 reports regarding deaths shortly after receiving the COVID-19 vaccinations. The vast majority involved elderly people who died between 1 and 33 days after the vaccination. Lareb announced in a news item that they were all in vulnerable health due to various serious underlying diseases and/or advanced age. RIVM is monitoring the developments closely.

09-03-2021 | 16:45 PM

Weekly update on COVID-19 vaccination: 28 February  to 7 March 2021

By Sunday 7 March, it is estimated that more than 1.2 million people in the Netherlands had received at least one COVID-19 vaccination, and over 400,000 people had received their second vaccination.

Direct to weekly update on COVID-19 vaccination

09-03-2021 | 16:13 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Number of positive COVID-19 tests at the same level as last week

Weekly Update 2 March 2021 to 9 March 2021

* Excluding results from large-scale testing in Bunschoten, Dronten and the Charlois neighbourhood of Rotterdam.  If the localised large-scale test results from these locations are included, the percentage of positive tests in the Netherlands is 8.0%. Not including the results from large-scale testing at these locations, the percentage of positive tests in the Netherlands is 8.1%.

¹GGD reports to RIVM between 2 March 10:01 and 9 March 10:00 as published 9 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 23 February 10:01 and 2 March 10:00 as published 2 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 2 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 2 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

08-03-2021 | 10:22 AM

CBS: Decrease in mortality among people aged 80 years and up

Based on the national provisional counts of the number of deaths per week, Statistics Netherlands (CBS) estimates that more than 3,200 people died in week 8 (22 to 28 February). This is fewer deaths than expected for this period, and nearly 300 fewer deaths than in the week before (3,491). A significant decrease was seen in mortality among people aged 80 years and up and people receiving care under the Long-Term Care Act (WLZ). 

RIVM also keeps track of mortality figures on a weekly basis, and has been tracking these figures since 2009 in cooperation with Statistics Netherlands. RIVM reports that mortality was elevated in the week of 18 to 24 February in all combined regions, with the exception of the Zeeland/Noord Brabant/Limburg region. A total of 3,348 deaths were reported in that week (354 more than the average expected mortality). We would normally expect to see between 2,830 and 3,157 deaths at this time of year. From 18 to 24 February, the reported mortality due to laboratory-confirmed COVID-19 was 322 deaths.

The method used by RIVM to estimate mortality is slightly different than the method used by Statistics Netherlands. Statistics Netherlands estimates excess mortality based on the average mortality per week in recent years, including increased mortality during unusual circumstances, such as a wave of seasonal influenza, or a heat wave. RIVM does not include the peaks during unusual circumstances in its calculations of average weekly mortality. The excess mortality estimates provided by Statistics Netherlands and RIVM complement each other.

02-03-2021 | 16:47 PM

Weekly update on COVID-19 vaccination: 21 to 28 February 2021

By Sunday 28 February, it is estimated that more than 1,000,000 people in the Netherlands had received at least one COVID-19 vaccination.

Vaccination started last week for mental health clients in inpatient or residential care at four large institutions and the mental healthcare workers employed there; they are being vaccinated by the institution’s own medical department. District nurses also started receiving their vaccinations last week.

Direct to weekly update on COVID-19 vaccination

02-03-2021 | 16:13 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Prospects not looking good yet

Weekly Update 24 February 2021 to 1 March 2021

* Excluding results from large-scale testing in Bunschoten, Dronten and the Charlois neighbourhood of Rotterdam.  If the localised large-scale test results from these locations are included, the percentage of positive tests in the Netherlands is 8.8%. Not including the results from large-scale testing at these locations, the percentage of positive tests in the Netherlands is 8.9%.

¹GGD reports to RIVM between 23 February 10:01 and 2 March 10:00 as published 2 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 16 February 10:01 and 13 February 10:00 as published 23 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 2 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 2 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

The number of newly reported infections that RIVM received last week from the Municipal Public Health Services (GGDs) is not the same as the number of positive tests in that week. The number of positive tests during the week could still change in response to delayed reports. These are newly reported infections that originate from test lanes, but also from hospitals and other sources. The number of infections in a week is expected to be higher than the number of positive tests, because it is likely that not everyone who is infected will get tested.

Not everyone who tests positive for COVID-19 is referred to as a patient. That term is used for people who are so ill that they need to be hospitalised, or for people who became so ill that they died. Not everyone who tests positive for COVID-19 becomes so ill that they have to be hospitalised. Many people only develop mild symptoms, or do not notice any symptoms at all.

In the past, we have referred to people who tested positive for COVID-19 as patients. This term has now been updated in our communications.

02-03-2021 | 14:00 PM

Lareb: biweekly report 

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 6,426 reports so far involving 31,534 possible side-effects. Over 1.3 million vaccinations have been given by now. Most of the reported symptoms are in line with side-effects that were already known. Since the start of the vaccination campaign, Lareb has received a total of 87 reports regarding deaths shortly after receiving the COVID-19 vaccinations. The reports involved elderly people who died between 1 and 26 days after the vaccination. Lareb announced in a news item that these deaths involved were vulnerable elderly people with serious underlying health problems and/or advanced age. RIVM is monitoring the developments closely. 

24-02-2021 I 14:27

OMT advisory report 19 February 2021

The Outbreak Management Team (OMT) convened on 19 February 2021 to advise on the situation surrounding the COVID-19 outbreak. The 101st OMT discussed:

• the course of the epidemic.
• the reproduction rate, effects of measures and prognoses.
• the virus variants.
• the night-time curfew and rule of 1 visitor at home per day.
• the effect of relaxing measures on the spread of the virus.
• relaxation of measures in secondary education, lower secondary vocational education (MBO) and upper secondary education (MBO), higher professional education (HBO) and university education (WO).
• pre-school and after-school care
• relaxation of measures in other sectors.

The OMT advice is published on the website of rijksoverheid.nl. More information about the OMT on the RIVM website. 

23-02-2021 | 16:13 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Measures prevent more rapid increase, but pressure on hospitals remains high.

Weekly Update 17 February to 23 February 2021

* Excluding results from large-scale testing in Bunschoten, Dronten and the Charlois neighbourhood of Rotterdam.  If the localised large-scale test results from these locations are included, the percentage of positive tests in the Netherlands is 9.7%. Not including the results from large-scale testing at these locations, the percentage of positive tests in the Netherlands is 9.8%.

¹GGD reports to RIVM between 16 February 10:01 and 23 February 10:00 as published 23 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 9 February 10:01 and 16 February 10:00 as published 16 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 23 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 23 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

23-02-2021 | 14.10 PM

Lareb: weekly report 

In its weekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 5,068 reports so far involving 24,031 possible side-effects. Over a million vaccinations have been given by now. One-half of a percent of the people who have been vaccinated reported one or more side-effects. Most of the reported symptoms are in line with side-effects that were already known. Since the start of the vaccination campaign, Lareb has received a total of 65 reports regarding deaths shortly after receiving the COVID-19 vaccinations. The reports involved elderly people who died between 1 and 26 days after the vaccination. Lareb announced in a news item (in Dutch) that they were all in vulnerable health due to various serious underlying diseases and/or advanced age. RIVM is monitoring the developments closely. 

9-2-2021 | 16:20 PM

Weekly update on COVID-19 vaccination: 1 to 7 February 2021

By Sunday 7 February, more than 500,000 people in the Netherlands had received their first COVID-19 vaccination. That also includes about 13,600 GPs. Last Friday, the first people in the age group from 80-84 years received an invitation to make an appointment for a COVID-19 vaccination at a Municipal Public Health Service (GGD).

Direct to weekly update on COVID-19 vaccination

09-02-2021 | 16:05 PM

For an explanation of the weekly COVID-19 figures, read the news: 

Weekly Update 3 February to 9 February 2021

¹GGD reports to RIVM between 2 February 10:01 and 9 February 10:00 as published 9 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 25 January 10:01 and 2 February 10:00 as published 2 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 9 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 9 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

02-02-2021 | 16:10 PM

RIVM joins European project on response to pandemics

Starting in February 2021, RIVM and Radboud University Medical Centre will be collaborating on the PANDEM-2 project. This project aims to increase and strengthen preparedness for and response to future pandemics. In that context, sharing information and collaborating are very important in order to protect the health and safety of people across the European Union. The PANDEM-2 project is funded by the European Union through Horizon 2020. The team from the Netherlands includes experts from Radboudumc and RIVM.

Read the Radboudumc press release (in Dutch)

02-02-2021 | 16:05 PM

For an explanation of the weekly COVID-19 figures, read the news: New variants disrupt plans

Weekly Update 27 January to 2 February 2021

*Excluding results from the municipality of Lansingerland due to large-scale testing in Lansingerland.

¹GGD reports to RIVM between 26 January 10:01 and 2 February 10:00 as published 2 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 19 January 10:01 and 26 January 10:00 as published 26 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 2 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week
_⁵ As published 2 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

29-1-2021 | 12:20 PM

Statistics Netherlands (CBS): Mortality still elevated: 3,800 deaths in week 3

Statistics Netherlands (CBS) reports in week 3 (18 to 24 January inclusive) that an estimated 3,850 people have died in the Netherlands. This is 450 more deaths than would normally be expected in this period. RIVM  also keeps track of mortality figures on a weekly basis (in Dutch). In the most recent RIVM data for 14 until 20 January, mortality was slightly elevated in the age category of 65 - 74 years and highly elevated in the age category 75 years and older. Mortality was higher in all combined regions.

26-1-2021 | 17:09 PM

More than 160 thousand people vaccinated in total

During the week of 18 to 24 January, more than 80 thousand people were vaccinated. Most of these were mainly care workers. Residents of institutions for people with intellectual disabilities and nursing homes also received their first vaccination. All vaccinated people still need to receive a second vaccination for optimal protection. As of 19 January, RIVM is publishing a weekly update on figures from the COVID-19 vaccination programme.

26-1-2021 | 16:35 PM

For an explanation of the weekly COVID-19 figures, read the news: UK variant gains ground in the Netherlands

Weekly Update 20 to 26 January 2021

*Excluding results from the municipality of Lansingerland due to large-scale testing in Lansingerland. If the localised large-scale test results from Lansingerland are included, the percentage of positive tests in the Netherlands is 11.0%. Not including the tests from Lansingerland, the percentage of positive tests in the Netherlands is 11.7%.

¹GGD reports to RIVM between 19 January 10:01 and 26 January 10:00 as published 26 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 12 January 10:01 and 19 January 10:00 as published 19 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 26 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week
_⁵ As published 26 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

19-1-2021 | 16:22 PM

Weekly RIVM update on vaccination figures

As of today, RIVM will be publishing an update every Tuesday on figures from the COVID-19-vaccination programme. Initial figures on the number of vaccinations that have been administered will be reported this week. The data will be updated and supplemented in the next few weeks. Eventually, the data will also be available in open data sets and on the coronavirus dashboard provided by the Dutch Government.

Read more

19-1-2021 | 16:00 PM

For an explanation of the weekly COVID-19 figures, read the news: Rise in new COVID-19 variants overshadows more positive developments

Weekly Update 13 to 19 January 2021

Not all of the reported hospital admissions or deaths occurred within the last week

*Excluding results from the municipality of Lansingerland due to large-scale testing in Lansingerland. If the localised large-scale test results from Lansingerland are included, the percentage of positive tests in the Netherlands is 11.0%. Not including the tests from Lansingerland, the percentage of positive tests in the Netherlands is 11.7%.

¹GGD reports to RIVM between 12 January 10:01 and 19 January 10:00 as published 19 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 5 January 10:01 and 12 January 10:00 as published 12 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 19 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
_⁴ As published 19 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

18-1-2021 | 17:40 PM

Study on Q fever and COVID-19

On Thursday 14 January 2021, RIVM National Institute for Public Health and the Environment   launched a study on Q fever and COVID-19 in the province of Noord-Brabant. Working with the Hart voor Brabant Municipal Public Health Service (GGD) and the Jeroen Bosch Hospital, among other parties, RIVM is researching whether people who had Q fever in 2007–2009 also have a higher risk of contracting COVID-19. Targeted invitations will be sent to potential participants for this study.

More information Q fever and COVID-19

12-1-2021 | 16:00 PM

For an explanation of the weekly COVID-19 figures, read the news: Tentative decrease becomes visible

Weekly Update 6 to 12 January 2021

Not all of the reported hospital admissions or deaths occurred within the last 24 hours

¹ GGD reports to RIVM National Institute for Public Health and the Environment   between 5 January10:01 and 12 January 10:00 as published 12 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
² GGD reports to RIVM between 29 December 10:01 and 5 January 10:00 as published 5 January 2020 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published  12 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ As published  12 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

5-1-2021 | 15:45 PM

For an explanation of the weekly COVID-19 figures, read the news: Decisive decrease not yet visible

Weekly Update 30 December 2020 - 5 January 2021

Not all of the reported hospital admissions or deaths occurred within the last 24 hours

¹ GGD reports to RIVM National Institute for Public Health and the Environment   between 29 December 10:01 and 5 January 10:00 as published 5 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
² GGD reports to RIVM between 22 December 10:01 and 29 December 10:00 as published 29 December 2020 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published  5 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ As published  5 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later.